Serum total oxidant/antioxidant status and trace element levels in breast cancer patients

International Journal of Clinical Oncology

Volumn 17, Issue 6, 2012, Pages 575-583

  Feng, Jia Fu ^a   Lu, Ling ^a   Zeng, Ping ^a   Yang, Yun Hong ^a   Luo, Jun ^a   Yang, Yu Wei ^a   Wang, Dong ^a  

^a MIANYANG CENTRAL HOSPITAL   (China)

Author keywords

Breast cancer; Oxidative stress; Oxidative stress index; Total antioxidant status; Total oxidant status; Trace element

Indexed keywords

COPPER; IRON; MAGNESIUM; MANGANESE; SELENIUM; TRACE ELEMENT; TUMOR MARKER; ZINC;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD LEVEL; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PRIORITY JOURNAL; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; TRACE ELEMENTS;

EID: 84875712692     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0327-y     Document Type: Article

References (56)

1. World Health Organization (2010) Breast cancer: prevention and control. http://www.who.int/cancer/detection/breastcancer/en/print.html (Accessed February 6, 2010)
2. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
3. Himmetoglu S, Dincer Y, Ersoy YE et al (2009) DNA oxidation and antioxidant status in breast cancer. J Investig Med 57:720-723
4. Mill CP, Chester JA, Riese DJ (2009) EGFR may couple moderate alcohol consumption to increased breast cancer risk. Breast Cancer (London) 2009:31-38
5. Cooke MS, Evans MD, Dizdaroglu M et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
6. Serefhanoglu K, Taskin A, Turan H et al (2009) Evaluation of oxidative status in patients with brucellosis. Braz J Infect Dis 13:249-251
7. Rao AK, Ziegler YS, McLeod IX et al (2008) Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol Endocrinol 22:1113-1124
8. Agnoletto MH, Guecheva TN, Dondé F et al (2007) Association of low repair efficiency with high hormone receptors expression and SOD activity in breast cancer patients. Clin Biochem 40:1252-1258
9. Rajneesh CP, Manimaran A, Sasikala KR et al (2008) Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J 49:640-643
10. Chariyalertsak S, Purisa W, Sangrajrang S (2009) Role of glutathione S-transferase omega gene polymorphisms in breast-cancer risk. Tumori 95:739-743
11. Badid N, Baba Ahmed FZ, Merzouk H et al (2010) Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 16:159-167
12. Gönenç A, Erten D, Aslan S et al (2006) Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 30:376-380
13. Melichar B, Kalábová H, Krcmová L et al (2009) Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma. Anticancer Res 29:3337-3346
14. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277-285
15. Cumurcu BE, Ozyurt H, Etikan I et al (2009) Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 63:639-645
16. Zhai S, Yang L, Cui QC S et al (2010) Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells. J Biol Inorg Chem 15:259-269
17. McGrath AP, Hilmer KM, Collyer CA et al (2009) Structure and inhibition of human diamine oxidase. Biochemistry 48:9810-9822
18. Hughes S, Samman S (2011) The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr 25:285-291
19. Andreini C, Bertini I, Cavallaro G et al (2008) Metal ions in biological catalysis: from enzyme databases to general principles. J Biol Inorg Chem 13:1205-1218
20. Pasha Q, Malik SA, Iqbal J et al (2008) Comparative evaluation of trace metal distribution and correlation in human malignant and benign breast tissues. Biol Trace Elem Res 125:30-40
21. Breedlove HA, Smith AM, Burk RF et al (2006) Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure. Breast Cancer Res Treat 97:225-230
22. Kuo HW, Chen SF, Wu CC et al (2002) Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res 89:1-11
23. Sharma K, Mittal DK, Kesarwani RC et al (1994) Diagnostic and prognostic significance of serum and tissue trace elements in breast malignancy. Indian J Med Sci 48:227-232
24. Moore AB, Shannon J, Chen C et al (2009) Dietary and stored iron as predictors of breast cancer risk: a nested case-control study in Shanghai. Int J Cancer 125:1110-1117
25. Helbich TH, Matzek W, Fuchsjäger MH (2004) Stereotactic and ultrasound-guided breast biopsy. Eur Radiol 14:383-393
26. Hammer C, Fanning A, Crowe J (2008) Overview of breast cancer staging and surgical treatment options. Cleve Clin J Med 75(Suppl 1):S10-S16
27. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103-1111
28. Harma M, Harma M, Erel O (2005) Oxidative stress in women with preeclampsia. Am J Obstet Gynecol 192:656-657
29. Aycicek A, Erel O, Kocyigit A (2005) Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 47:635-639
30. Aycicek A, Erel O (2007) Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 83:319-322
31. Sener DE, Gönenç A, Akinci M et al (2007) Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 25:377-382
32. Ray G, Husain SA (2001) Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34:71-76
33. Polat MF, Taysi S, Gul M et al (2002) Oxidant/antioxidant status in blood of patients with malignant breast tumor and benign breast disease. Cell Biochem Funct 20:327-331
34. Kasapović J, Pejić S, Todorović A et al (2008) Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 26:723-730
35. Khanzode SS, Muddeshwar MG, Khanzode SD et al (2004) Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res 38:81-85
36. Lee SA, Lee KM, Lee SJ et al (2010) Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk. Nutr Cancer 62:1087-1094
37. Sova H, Jukkola-Vuorinen A, Puistola U et al (2010) 8- Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer 102:1018-1023
38. Muralikrishnan G, Amanullah S, Basha MI et al (2010) Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients. Chemotherapy 56:298-302
39. Thomson CA, Stendell-Hollis NR, Rock CL et al (2007) Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev 16:2008-2015
40. Li Y, Ambrosone CB, McCullough MJ et al (2009) Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis 30:777-784
41. Hong CC, Ambrosone CB, Ahn J et al (2007) Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 16:1784-1794
42. Huang X (2008) Does iron have a role in breast cancer? Lancet Oncol 9:803-807
43. Bae YJ, Yeon JY, Sung CJ et al (2009) Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients. J Clin Biochem Nutr 45:355-360
44. Charalabopoulos K, Kotsalos A, Batistatou A et al (2006) Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Cancer 95:674-676
45. Suzana S, Cham BG, Ahmad Rohi G et al (2009) Relationship between selenium and breast cancer: a case-control study in the Klang Valley. Singapore Med J 50:265-269
46. Wu HD, Chou SY, Chen DR et al (2006) Differentiation of serum levels of trace elements in normal and malignant breast patients. Biol Trace Elem Res 113:9-18
47. You Z, Cao X, Taylor AB et al (2010) Characterization of a covalent polysulfane bridge in copper-zinc superoxide dismutase. Biochemistry 49:1191-1198
48. Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L (2003) Selenium in breast cancer. Oncology 64:227-231
49. Reddi AR, Jensen LT, Naranuntarat A et al (2009) The overlapping roles of manganese and Cu/Zn SOD in oxidative stress protection. Free Radic Biol Med 46:154-162
50. Desoize B (2003) Metals and metal compounds in carcinogenesis. In Vivo 17:529-539
51. Hasebe N (2005) Oxidative stress and magnesium. Clin Calcium 15:194-202
52. Valko M, Rhodes CJ, Moncol J et al (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40
53. Valko M, Morris H, Cronin MT (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12:1161-1208
54. Afrasyap L, Güvenen G, Türkmen S (1998) Plasma and erythrocyte total antioxidant status in patients with benign and malign breast disease. Cancer Biochem Biophys 16:129-138
55. Injac R, Perse M, Obermajer N et al (2008) Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 29:3451-3460
56. Atakisi E, Kart A, Atakisi O et al (2009) Acute tamoxifen treatment increases nitric oxide level but not total antioxidant capacity and adenosine deaminase activity in the plasma of rabbits. Eur Rev Med Pharmacol Sci 13:239-243